Older adults who undergo hemodialysis for kidney failure have been shown to have a decline in cognition at the time of treatment. With this in mind, Dr. Mara McAdams-DeMarcho and her team led research to understand the risk of developing dementia in correlation to hemodialysis treatment.
New research from a team of researchers from the University of Washington School of Medicine, the Kaiser Permanente Washington Health Institute and the UW School of Nursing have found a correlation between disease of the eye and development of dementia.
Researchers from the Technical University of Munich have come closer to finding a way to combat amyloid plaques, a protein that characterizes in Alzheimer’s disease. They designed a highly potent inhibitor of amyloid plaque formation in a new class of macrocyclic peptides.
With dementia, there are molecular processes and changes in the brain that occur years before symptoms are noticeable. Researchers at the University of Virginia are looking into how dementia develops at the molecular level before neuronal damage and symptoms are present. Specifically, researchers are investigating whether memantine, a medication commonly used in alleviating symptoms of moderate dementia, could slow or prevent progression of dementia if used before symptoms appear.